KALA BIO (KALA) vs Pulmatrix (PULM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
KALA BIO is the larger company by market cap ($5.7 million vs $5.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KALA | PULM |
|---|---|---|
| Share price | $0.2966 | $1.53 |
| Market cap | $5.74M | $5.58M |
| 1-day change | -17.61% | +2.49% |
| EPS (TTM) | $-10.71 | $-1.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $95.50 | $5.24 |
| 52-week low | $0.2915 | $1.16 |
| Distance from 52-week high | -99.69% | -70.83% |
| Average volume | 1.46M | 24.09K |
| Shares outstanding | 19.34M | 3.65M |
| Employees | 6 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About KALA BIO
KALA stock →KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment.
Healthcare · Biotechnology · 6 employees
About Pulmatrix
PULM stock →Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Healthcare · Biotechnology · 2 employees
KALA vs PULM FAQ
Which is bigger, KALA BIO or Pulmatrix?
KALA BIO (KALA) is larger, with a market capitalization of $5.74M compared with $5.58M for Pulmatrix (PULM).
Are KALA BIO and Pulmatrix in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.